Absorption |
Blood-Brain Barrier | BBB+ | 0.9702 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.6493 |
P-glycoprotein Substrate | Non-substrate | 0.6137 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9246 |
Non-inhibitor | 0.9794 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8244 |
Distribution |
Subcellular localization | Lysosome | 0.5431 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8092 |
CYP450 2D6 Substrate | Non-substrate | 0.8245 |
CYP450 3A4 Substrate | Non-substrate | 0.7149 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6695 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8656 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9365 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7930 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9822 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9644 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.8899 |
Non-inhibitor | 0.9654 |
AMES Toxicity | AMES toxic | 0.8136 |
Carcinogens | Non-carcinogens | 0.6969 |
Fish Toxicity | Low FHMT | 0.9777 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.9659 |
Honey Bee Toxicity | High HBT | 0.6801 |
Biodegradation | Ready biodegradable | 0.8189 |
Acute Oral Toxicity | II | 0.5595 |
Carcinogenicity (Three-class) | Non-required | 0.4216 |